• ̍̍ CSE: BRAX
  • ̍̍ OTC: BRAXF
  • ̍̍ FWB: 4960

Daniel Herrera VP, R&D and Growth, Braxia Scientific

Daniel Herrera

VP, R&D and Growth, Braxia Scientific

As Vice President, Research & Development and Growth, Daniel Herrera brings extensive experience in the life sciences industry including more than 15 years of senior-level experience in the pharmaceutical industry serving in various commercial and strategic roles at Eli Lilly and Company. Daniel has also led various teams and divisions at high-growth start-ups and private multi-national companies in the pharmaceutical and cannabis industries. In these roles he has acquired regulatory and commercial knowledge and expertise in various therapeutic areas, including cardiovascular, pulmonary, metabolic and mental health.

In this strategic role, Daniel will drive Braxia’s R&D portfolio strategy and business development to further strengthen the Company’s pipeline by leveraging internal and external opportunities.